GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Change in Receivables came in at $79.0 million in Q2 2026, up 175.96% on a YoY basis from $28.6 million in Q2 2025, and up 156.03% quarter-over-quarter from -$141.0 million in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Change in Receivables for 5 consecutive years, with $79.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 175.96% year-over-year to $79.0 million; the trailing twelve-month figure through Jun 2026 stood at $339.0 million (up 245.92% YoY), and the FY2025 full-year result was $216.0 million, up 37.58% from the prior year.
- Change in Receivables advanced to $79.0 million in Q2 2026 per GEHC's latest filing, from -$141.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $258.0 million in Q4 2024 and bottomed at -$165.0 million in Q1 2024.
- Historically, Change in Receivables has averaged $39.7 million across 5 years, with a median of $32.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables plunged 850.0% in 2024, then surged 664.0% in 2025.
- Over 5 years, Change in Receivables stood at $124.0 million in 2022, then decreased by 26.61% to $91.0 million in 2023, then soared by 183.52% to $258.0 million in 2024, then fell by 18.6% to $210.0 million in 2025, then slumped by 62.38% to $79.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $79.0 million, -$141.0 million, and $210.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 79.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -3.28 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 9.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 10.05 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -8.90 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 283,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | -3.20 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -2.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.00 Mn |
| Mar 31, 2026 | -141.00 Mn |
| Dec 31, 2025 | 210.00 Mn |
| Sep 30, 2025 | 191.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Mar 31, 2025 | -81.00 Mn |
| Dec 31, 2024 | 258.00 Mn |
| Sep 30, 2024 | 25.00 Mn |
| Jun 30, 2024 | 39.00 Mn |
| Mar 31, 2024 | -165.00 Mn |
| Dec 31, 2023 | 91.00 Mn |
| Sep 30, 2023 | 50.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 22.00 Mn |
| Dec 31, 2022 | 124.00 Mn |
| Sep 30, 2022 | -54.00 Mn |
| Jun 30, 2022 | 22.00 Mn |
| Mar 31, 2022 | 139.00 Mn |